Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Washington, DC
NPI: 1083939102Primary Practice Location
MEDSTAR WASHINGTON HOSPITAL CENTER
110 Irving St Nw, Washington, DC
Primary Employer
Medstar Medical Group II LLC
medstarhealth.org
HQ Phone
Get M.D. Ami's Phone Numberphone_androidMobile
Get M.D. Ami's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 178 | 274 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 93 | 291 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 36 | 38 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 27 | 39 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 13 | 13 |
Authors: Antonio Wolff, Andrew Davis, David Cella, Erica Stringer-Reasor, Shamsuddin Virani, Angela Demichele, Tarah Ballinger, Jason Incorvati, Della Makower, Bryan Schneider, Joseph Sparano
Journal: J Clin Oncol
Publication Date: 2024-06-03
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Seagen Inc.
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Placebo Administration, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Tucatinib
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel
